Law channel feed – Endpoints News

Law channel feed

Lack of detail in Trump's drug price plan raises more questions than answers

15 hours ago

PBM overhaul and drug price negotiations make the cut in Republicans' tax bill

17 hours ago

AstraZeneca loses appeals court fight over IRA drug price negotiations

4 days ago

Avadel can pursue label expansion for narcolepsy drug Lumryz after court ruling

5 days ago

Compounders just lost their case to put obesity drug tirzepatide back in shortage

5 days ago

States sue US over plan for reorganization of federal health agencies

6 days ago

Exclusive: SEC expected to drop investigation of Illumina's $8B Grail deal

6 days ago

BeiGene scores a win from US Patent Office in spat over Brukinsa

Last week

Regeneron loses bid to fend off DOJ fight over Eylea Medicare payments

Last week

AstraZeneca posts another Truqap study fail, says China import tax could triple

2 weeks ago

New House bill would cut tax deductions pharma companies receive for ads

2 weeks ago

Compounding pharmacies dealt a blow in fight over end of semaglutide shortage

3 weeks ago

Halozyme sues Merck, alleging injectable Keytruda will infringe its patents

3 weeks ago

Top pharma companies increased lobbying spend in first quarter of 2025

3 weeks ago

Eli Lilly sues four telehealth companies selling compounded tirzepatide

3 weeks ago

Recent FDA staff cuts to delay drug hearing decision by months, agency tells Vanda

3 weeks ago

Alvogen unit appeals court loss shielding Bausch Health's IBS drug from generics

3 weeks ago

Pharma's wins and losses in Trump's sprawling executive order on drug prices

4 weeks ago

Trump pledges his support for a change to the IRA long sought by drugmakers

4 weeks ago

Sandoz sues Amgen over nine-year launch delay for Enbrel biosimilar

4 weeks ago

Primate researchers cope with uncertainty as NIH appeals for payment cuts in court

4 weeks ago

Firings of HHS' probationary workers can proceed, appeals court says

Last month

House panel mulls ways to boost struggling US biosimilar market

Last month

NIH appeals nationwide block on payment cap for research grantees

Last month

12 3 4 Next page Last page

	
		OSZAR »